MedPath

Partnership for Glaucoma

Not Applicable
Completed
Conditions
Glaucoma
Interventions
Other: Computer Tablet
Other: Continuing education
Other: Continuing Education Course
Registration Number
NCT00672048
Lead Sponsor
Duke University
Brief Summary

The purpose of this study is to develop new ways of assisting patients with glaucoma and their eye doctors in using the recommendations from practice guidelines.

Detailed Description

Glaucoma is a leading cause of blindness and visual impairment in the United States, particularly among disadvantaged populations. Despite the presence of therapies proven in NEI, randomized controlled trials that can be delivered by more than 18,000 ophthalmologists and 34,000 optometrists, almost nothing is known about the content and quality of glaucoma care delivered by non-MD providers such as optometrists. With the numbers of people with glaucoma expected to more than double in the next twenty years in the face of no more than a 15% increase in the supply of eye care providers, methods to better support appropriate and high-quality care for chronic eye diseases such as glaucoma delivered by optometrists will become as critical, if not more so, as techniques to enhance quality care among ophthalmologists.

Our study is a community-based, randomized, controlled trial that evaluates the suitability and effectiveness of a technology-based (tablet computer) intervention within the context of a novel partnership between optometrists and patients with glaucoma to improve the process quality of care and ultimately outcomes of care. By using successfully implemented technology in novel applications,and by building on the success of ongoing community-based quality improvement projects in our region, the study provides a means for rapid translation into community care if the intervention is successful.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
721
Inclusion Criteria

-Diagnosis of open angle glaucoma with documented visual field loss.

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Computer Tablet-
1Continuing Education Course-
2Continuing educationControl group to receive annual continuing education
Primary Outcome Measures
NameTimeMethod
To determine if innovative technology will improve process quality of care & important outcomes of care by optometrists in a cost-efficient manner while simultaneously empowering & including patients as part of the care process.Baseline, Year 1 and Year 2
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Duke University

🇺🇸

Durham, North Carolina, United States

University of Alabama

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath